Hanall Biopharma한올바이오파마
009420 · KOSPI · ₩009420 · 한올바이오파마
₩37,800▼ ₩700 (1.82%)End-of-day · Oct 29, 2026 · End-of-day prices.
Filings
- Preliminary earnings (consolidated)연결재무제표기준영업(잠정)실적(공정공시)Oct 28, 2026Open on DART
Predicted impact: Medium
Preliminary earnings with no figures given; recent China approval may influence results, size unknown
- Insider shareholding report임원ㆍ주요주주특정증권등소유상황보고서Oct 6, 2026Open on DART
- Half-year report (Jun 2026)반기보고서 (2026.06)Aug 14, 2026Open on DART
- Investor relations (IR) event기업설명회(IR)개최(안내공시)Jul 31, 2026Open on DART
- Preliminary earnings (consolidated)연결재무제표기준영업(잠정)실적(공정공시)Jul 29, 2026Open on DART
- Amended: Major management matter relevant to investors[기재정정]투자판단관련주요경영사항Jul 22, 2026Open on DART
- Major management matter relevant to investors투자판단관련주요경영사항Jul 22, 2026Open on DART
- Insider shareholding report임원ㆍ주요주주특정증권등소유상황보고서Jul 2, 2026Open on DART
- 5%+ holding report주식등의대량보유상황보고서(약식)Jul 1, 2026Open on DART
- Disclosure Related to Sustainability Management Report, etc. (Voluntary Disclosure)지속가능경영보고서등관련사항(자율공시)Jun 30, 2026Open on DART
- Disclosure of Corporate Governance Report기업지배구조보고서공시Jun 1, 2026Open on DART
- Investor relations (IR) event기업설명회(IR)개최(안내공시)May 28, 2026Open on DART
- Amended: Major management matter relevant to investors[기재정정]투자판단관련주요경영사항May 20, 2026Open on DART
- Quarterly report (Mar 2026)분기보고서 (2026.03)May 15, 2026Open on DART
- Change in largest shareholder's holdings최대주주등소유주식변동신고서May 6, 2026Open on DART
- Report on Results of Disposal of Treasury Shares자기주식처분결과보고서May 6, 2026Open on DART
- Insider shareholding report임원ㆍ주요주주특정증권등소유상황보고서May 6, 2026Open on DART
- Insider shareholding report임원ㆍ주요주주특정증권등소유상황보고서May 6, 2026Open on DART
- Insider shareholding report임원ㆍ주요주주특정증권등소유상황보고서May 6, 2026Open on DART
- Preliminary earnings (consolidated)연결재무제표기준영업(잠정)실적(공정공시)Apr 29, 2026Open on DART
- Treasury share sale decision주요사항보고서(자기주식처분결정)Apr 29, 2026Open on DART
- Investor relations (IR) event기업설명회(IR)개최(안내공시)Apr 13, 2026Open on DART
- Insider shareholding report임원ㆍ주요주주특정증권등소유상황보고서Apr 7, 2026Open on DART
- Major management matter relevant to investors투자판단관련주요경영사항Apr 2, 2026Open on DART
- 5%+ holding report주식등의대량보유상황보고서(약식)Apr 1, 2026Open on DART
- Report on Appointment, Dismissal, or Mid-Term Resignation of Independent Directors독립이사의선임ㆍ해임또는중도퇴임에관한신고Mar 27, 2026Open on DART
- Change of Representative Director (Representative Executive Officer) (Informational Disclosure)대표이사(대표집행임원)변경(안내공시)Mar 26, 2026Open on DART
- Annual general meeting results정기주주총회결과Mar 26, 2026Open on DART
- Annual report (Dec 2025)사업보고서 (2025.12)Mar 18, 2026Open on DART
- Report on Results of Disposal of Treasury Shares자기주식처분결과보고서Mar 11, 2026Open on DART
- Audit report submitted감사보고서제출Mar 9, 2026Open on DART
- Treasury share sale decision주요사항보고서(자기주식처분결정)Mar 9, 2026Open on DART
- Report on Results of Disposal of Treasury Shares자기주식처분결과보고서Mar 3, 2026Open on DART
- Shareholders' meeting called주주총회소집결의Feb 25, 2026Open on DART
- Notice of shareholders' meeting주주총회소집공고Feb 25, 2026Open on DART
- Treasury share sale decision주요사항보고서(자기주식처분결정)Feb 25, 2026Open on DART
- Change in revenue or profit of 30% or more매출액또는손익구조30%(대규모법인은15%)이상변경Jan 21, 2026Open on DART
- Preliminary earnings (consolidated)연결재무제표기준영업(잠정)실적(공정공시)Jan 21, 2026Open on DART
- 5%+ holding report주식등의대량보유상황보고서(약식)Jan 2, 2026Open on DART
- [Corrected] New Facility Investment, etc.[기재정정]신규시설투자등Dec 19, 2025Open on DART
- Determination of Shareholder Register Closure Period or Record Date주주명부폐쇄기간또는기준일설정Dec 15, 2025Open on DART
- Investor relations (IR) event기업설명회(IR)개최(안내공시)Nov 25, 2025Open on DART
- Investor relations (IR) event기업설명회(IR)개최(안내공시)Nov 25, 2025Open on DART
- Quarterly report (Sep 2025)분기보고서 (2025.09)Nov 14, 2025Open on DART
- [Amended] Timely Disclosure Obligation Matters (Fair Disclosure)[기재정정]수시공시의무관련사항(공정공시)Oct 29, 2025Open on DART
- Change in largest shareholder's holdings최대주주등소유주식변동신고서Oct 29, 2025Open on DART
- Matters Related to Timely Disclosure Obligations (Fair Disclosure)수시공시의무관련사항(공정공시)Oct 29, 2025Open on DART
- Preliminary earnings (consolidated)연결재무제표기준영업(잠정)실적(공정공시)Oct 29, 2025Open on DART
- Report on Results of Disposal of Treasury Shares자기주식처분결과보고서Oct 29, 2025Open on DART
- Insider shareholding report임원ㆍ주요주주특정증권등소유상황보고서Oct 29, 2025Open on DART
Titles in Korean until English translations are added.
Also known as: Hanall Biopharma / 한올바이오파마 / 009420 / KRX:009420
Source: KRX statistical information